Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
1.22%
Insider Ownership
0.65%
Institutional Own.
6.13%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Exebacase (CF-301) (DLA) Details Prosthetic joint infection, Bacteremia | Phase 1/2 Data readout | |
CF-370 Details Pneumonia | Phase 1 Initiation | |
Exebacase (CF-301) (DLA) Details Staph aureus | Failed Discontinued |